Company
Every investor coverage indicates participated in a round United States Food and Drug Administration (FDA) raised.
Companies United States Food and Drug Administration (FDA) acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming United States Food and Drug Administration (FDA). Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Telix Pharmaceuticals has gained US regulatory clearance for its glioma imaging agent Pixclara, a world first, and is now studying the compound in late-stage trials for brain metastases.
OncoSil Medical has raised $5.6m from three large existing shareholders to fund overseas and domestic launches of its radiation therapy, after winning TGA and FDA clearances for pancreatic and bile duct cancer use.
Roundup of Australian manufacturing briefs: Provaris bids for a hydrogen tank production cell, Lithium Australia wraps a share purchase plan, QEM launches a rights issue, and Laronix hires a speech pathologist.
Sunshine Heart won complete US regulator clearance to run its first American trial of the C-Pulse heart device, having satisfied conditions attached to September's conditional clearance; enrolment of trial participants was anticipated that year.